CRTX — CRISM' Therapeutics Share News
0.000.00%
Last trade - 00:00- £7.13m
- £4.86m
- £0.23m
Crism Therapeutics: Director Dealing
Crism Therapeutics: Clinical Trial Update
Crism Therapeutics: European Patent Grant
Crism Therapeutics: Interim Results
Crism Therapeutics: Notice of Interim Results & IMC Presentation
RCS - CRISM Therapeutics - Delivery Method Validated in Peer Reviewed Journal
Brief: Crism Therapeutics Signs Service Agreement With Value Of £230,000
Crism Therapeutics - Response to Movement in Share Price
Crism Therapeutics - Director Dealing
Brief: Amur Minerals Corp To Buy Extruded Pharmaceuticals
Amur Minerals Corp - Proposed Reverse Takeover
Amur Minerals Corp - AUDITED FINAL RESULTS
Amur Minerals Corp - AIM Rule 17 Schedule Two (g) update
Brief: Amur Minerals Expects To Publish An Aim Admission Document Before End Of April 2024
Amur Minerals Corp - Company Update
Amur Minerals Corp - Notice of Annual General Meeting
Amur Minerals Corp - Interim Results 2023
Brief: Amur Minerals Corp Says Shares On AIM will Be Suspended
Brief: Amur Minerals Says Continues To Review Number Of Reverse Takeover Opportunities